Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation

This study is evaluating how well Botulinum Toxin Type A (commonly known as Botox) reduces facial wrinkles on the forehead and between the brows, and how safe it is for people from different financial backgrounds. Researchers also want to find the best dose to achieve cosmetic improvement with the fewest side effects. Adults aged 20 to 65 in good health who have moderate forehead or glabellar wrinkles can participate, though those who are pregnant, have neuromuscular disorders, or have had recent facial procedures in the treatment area are not eligible. Participation involves receiving an injection and attending follow-up visits to assess wrinkle reduction and patient satisfaction. This summary was prepared with AI assistance to help patients understand the study in plain language.